Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Naproxen versus placebo with standard antimicrobial treatment in ICU patients with severe acute respiratory syndrome during the COVID-19 pandemic
RBR-3rywwgPhase 2Recruiting
- Sponsor
- FUNFARME
- Start
- Jun 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial in severe acute respiratory syndrome (SARS) and coronavirus pneumonia comparing Naproxen plus standard treatment with Placebo plus standard treatment (2 arms). Started Jun 2020; status: recruiting.
02
Drugs
naproxen
03
Conditions
severe acute respiratory syndrome (SARS)coronavirus pneumonia
Beyond the preview
Go deeper on RBR-3rywwg.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on RBR-3rywwg.